EP1392676 - HETEROCYCLIC UREA DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.10.2007 Database last updated on 02.11.2024 | Most recent event Tooltip | 13.03.2020 | Change - lapse in a contracting state State(s) deleted from list of lapses: TR | published on 15.04.2020 [2020/16] | Applicant(s) | For all designated states Aventis Pharmaceuticals Inc. 300 Somerset Corporate Boulevard Bridgewater, NJ 08807 / US | [N/P] |
Former [2006/47] | For all designated states AVENTIS PHARMACEUTICALS INC. 300 Somerset Corporate Boulevard Bridgewater, NJ 08807 / US | ||
Former [2006/44] | For all designated states Aventis Pharmaceuticals, Inc. 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807 / US | ||
Former [2004/10] | For all designated states Aventis Pharmaceuticals, Inc. 300 Somerset Corporate Boulevard Bridgwater, New Jersey 08807-2854 / US | Inventor(s) | 01 /
HENDRIX, James, A. 4 Aspen Drive Hillsborough, NJ 08876 / US | 02 /
STRUPCZEWSKI, Joseph, T. 4 Stewart Lane Flemington, NJ 08822 / US | 03 /
BORDEAU, Kenneth, J. 211 Durham-Nox Road Kintnersville, PA 18930 / US | 04 /
BROOKS, Sarah 276 Massachusetts Avenue, Apt. 104 Arlington, MA 02174 / US | 05 /
HEMMERLE, Horst Oranienstrasse 11a D-65812 Bad Soden / DE | 06 /
URMANN, Matthias Im Sylvaner 4b D-65760 Eschborn / DE | 07 /
ZHAO, Xu-Yang 7 Decker Lane Bridgewater, NJ 08807 / US | 08 /
MUELLER, Paul, Justin. 1300 Clinton Street, Apt. 326 Hoboken, NJ 07030 / US | [2004/10] | Representative(s) | Fischer, Hans-Jürgen, et al Sanofi-Aventis Deutschland GmbH Patent- und Lizenzabteilung Industriepark Höchst Gebaüde K 801 65926 Frankfurt am Main / DE | [N/P] |
Former [2004/10] | Fischer, Hans-Jürgen, et al Aventis Pharma Deutschland GmbH, Patent- und Lizenzabteilung, Gebäude K 801 65926 Frankfurt am Main / DE | Application number, filing date | 02714914.5 | 15.02.2002 | [2004/10] | WO2002US04560 | Priority number, date | US20010269654P | 16.02.2001 Original published format: US 269654 P | GB20010017950 | 23.07.2001 Original published format: GB 0117950 | [2004/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO02066468 | Date: | 29.08.2002 | Language: | EN | [2002/35] | Type: | A2 Application without search report | No.: | EP1392676 | Date: | 03.03.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.08.2002 takes the place of the publication of the European patent application. | [2004/10] | Type: | B1 Patent specification | No.: | EP1392676 | Date: | 13.12.2006 | Language: | EN | [2006/50] | Search report(s) | International search report - published on: | EP | 17.10.2002 | Classification | IPC: | C07D333/62, C07D333/54, C07D498/04, C07D495/04, A61K31/381, A61P25/18 | [2004/10] | CPC: |
C07D231/12 (EP);
A61P13/12 (EP);
A61P25/00 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P43/00 (EP);
C07D233/56 (EP);
C07D249/08 (EP);
C07D333/66 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/10] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | HETEROCYCLISCHE HARNSTOFFDERIVATE UND DEREN VERWENDUNG ALS DOPAMINE D3 RECEPTOR LIGANDEN | [2004/10] | English: | HETEROCYCLIC UREA DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS | [2004/10] | French: | NOUVEAUX DERIVES D'UREE HETEROCYCLIQUES ET LEUR UTILISATION EN TANT QUE LIGANDS DES RECEPTEURS DE LA DOPAMINE D3 | [2004/10] | Entry into regional phase | 16.09.2003 | National basic fee paid | 16.09.2003 | Designation fee(s) paid | 16.09.2003 | Examination fee paid | Examination procedure | 16.09.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 16.09.2003 | Examination requested [2004/10] | 08.03.2004 | Despatch of a communication from the examining division (Time limit: M06) | 20.09.2004 | Reply to a communication from the examining division | 11.01.2006 | Despatch of a communication from the examining division (Time limit: M04) | 11.05.2006 | Reply to a communication from the examining division | 12.06.2006 | Communication of intention to grant the patent | 23.10.2006 | Fee for grant paid | 23.10.2006 | Fee for publishing/printing paid | Opposition(s) | 14.09.2007 | No opposition filed within time limit [2007/47] | Fees paid | Renewal fee | 01.03.2004 | Renewal fee patent year 03 | 28.02.2005 | Renewal fee patent year 04 | 28.02.2006 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 13.12.2006 | LU | 15.02.2007 | MC | 28.02.2007 | [2020/16] |
Former [2015/21] | CY | 13.12.2006 | |
LU | 15.02.2007 | ||
TR | 15.02.2007 | ||
MC | 28.02.2007 | ||
Former [2013/10] | CY | 13.12.2006 | |
LU | 15.02.2007 | ||
MC | 28.02.2007 | ||
Former [2009/42] | CY | 13.12.2006 | |
TR | 13.12.2006 | ||
LU | 15.02.2007 | ||
MC | 28.02.2007 | ||
Former [2009/38] | CY | 13.12.2006 | |
LU | 15.02.2007 | ||
MC | 28.02.2007 | ||
Former [2007/48] | MC | 28.02.2007 | Cited in | International search | [Y]EP0395313 (AMERICAN HOME PROD [US], et al) [Y] 1-47 * examples 1,2; claim - *; | [A]US5393761 (PERREGAARD JENS K [DK], et al) [A] 1-47 * column 7, line 66 - column 8, line 20; examples 13,15; claim 1 *; | [A]US5990114 (LEONARDI AMEDEO [IT], et al) [A] 1-47 * column 15, line 57 - line 58; claim 1 * * column 16, line 1 - line 5 *; | [DA]WO0067847 (BASF AG [DE], et al) [DA] 1-47 * page 3, line 1 - page 6, line 20; examples 1,2,12 *; | [Y] - ISHIZUMI K ET AL, "Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds.", MEDLINE, (199512), Database accession no. NLM8582016, XP002204864 [Y] 1-47 * abstract * | [ ] - CROSSFIRE BEILSTEIN, BEILSTEIN INSTITUT ZUR FOERDERUNG DER WISSENSCHAFTEN, FRANKFURT AM MAIN, DE, XP002204865 [ ] * abstract * | [ ] - ISHIZUMI K ET AL, "Succinimide derivatives. II. Synthesis and antipsychotic activity of N-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)1,2-cis-cyclohexanedicarboximide (SM-9018) and related compounds", CHEMICAL & PHARMACEUTICAL BULLETIN, JAPAN DEC 1995, (199512), vol. 43, no. 12, pages 2139 - 2151 | [A] - MURRAY P J ET AL, "A novel series of arylpiperazines with high affinity and selectivity for the dopamine D3 receptor", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19950202), vol. 5, no. 3, ISSN 0960-894X, pages 219 - 222, XP004135762 [A] 1-47 * page 220; table 1 * DOI: http://dx.doi.org/10.1016/0960-894X(95)00011-H | [Y] - SOKOLOFF P ET AL, "MOLECULAR CLONING AND CHARACTERIZATION OF A NOVEL DOPAMINE RECEPTOR(D3) AS A TARGET FOR NEUROLEPTICS", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, (19900913), vol. 347, ISSN 0028-0836, pages 146 - 151, XP000652293 [Y] 1-47 * page 150, column R, paragraph 2 * DOI: http://dx.doi.org/10.1038/347146a0 |